Management of noninfectious mixed cryoglobulinemia vasculitis: Data from 242 cases included in the CryoVas survey

Blood

Volumn 119, Issue 25, 2012, Pages 5996-6004

  Terrier, Benjamin ^a   Krastinova, Evguenia ^b   Marie, Isabelle ^c   Launay, David ^d   Lacraz, Adeline ^e   Belenotti, Pauline ^f   De Saint Martin, Luc ^g   Quemeneur, Thomas ^h   Huart, Antoine ⁱ   Bonnet, Fabrice ^e   Le Guenno, Guillaume ^j   Kahn, Jean Emmanuel ^k   Hinschberger, Olivier ^l   Rullier, Patricia ^m   Diot, Elisabeth ⁿ   Lazaro, Estibaliz ^e   Bridoux, Frank ^o   Zénone, Thierry ^p   Carrat, Fabrice ^b   Hermine, Olivier ^q   Léger, Jean Marc ^r   Mariette, Xavier ^s,t   Senet, Patricia ^u   Plaisier, Emmanuelle ^u   Cacoub, Patrice ^a   more..

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d Centre Hospitalier Régional et Universitaire Claude Huriez   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^g BREST UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER DE VALENCIENNES   (France)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k FOCH HOSPITAL   (France)

^l CENTRE HOSPITALIER DE MULHOUSE   (France)

^m MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITY HOSPITAL OF TOURS   (France)

^o POITIERS UNIVERSITY HOSPITAL   (France)

^p CENTRE HOSPITALIER DE VALENCE   (France)

^q HÔPITAL NECKER ENFANTS MALADES   (France)

^r PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^s BICÊTRE HOSPITAL   (France)

^t UNIVERSITÉ PARIS SACLAY   (France)

^u HÔPITAL TENON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE; RITUXIMAB;

ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; CRYOGLOBULINEMIA VASCULITIS; DRUG EFFICACY; FEMALE; GLOMERULONEPHRITIS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PURPURA; SKIN NECROSIS; SKIN ULCER; TREATMENT DURATION;

EID: 84862732615     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-12-396028     Document Type: Article

References (24)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57(5):775-788.
2. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42(10):2204-2212. (Pubitemid 30263607)
3. Trejo O, Ramos-Casals M, Garcia-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001;80(4):252-262. (Pubitemid 32703064)
4. Saadoun D, Sellam J, Ghillani-Dalbin P, Crecel R, Piette JC, Cacoub P. Increased risks of lymphoma and death among patients with nonhepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med. 2006;166(19):2101-2108. (Pubitemid 44631398)
5. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55(1):4-13. (Pubitemid 34081673)
6. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980;69(2):287-308. (Pubitemid 10036826)
7. Saadoun D, Resche Rigon M, Sene D, et al. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010;116(3):326-334; quiz 504-505.
8. Dammacco F, Tucci FA, Lauletta G, et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood. 2010;116(3):343-353.
9. Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int. 1995;47(2):618-623.
10. Terrier B, Launay D, Kaplanski G, et al. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken). 2010;62(12):1787-1795.
11. Casato M, Lilli D, Donato G, et al. Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J Viral Hepat. 2003;10(6):455-459. (Pubitemid 37352588)
12. Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010;39(3):284-291.
13. Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009;49(2):665-675.
14. Halfon P, Bourliere M, Ouzan D, et al. Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol. 2008; 46(6):2106-2108. (Pubitemid 351831855)
15. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21):1512-1523. (Pubitemid 27495778)
16. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523-531.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470. (Pubitemid 29135798)
18. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran ME, Berry D, eds. Statistical Models in Epidemiology, the Environment and Clinical Trials. New York, NY: Springer-Verlag; 1999:95-134.
19. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560. (Pubitemid 30660034)
20. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561-570. (Pubitemid 30660035)
21. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656-664.
22. Cacoub P, Lidove O, Maisonobe T, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46(12):3317-3326. (Pubitemid 35453543)
23. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum. 2006;54(11):3696-3706. (Pubitemid 44737183)
24. Terrier B, Semoun O, Saadoun D, Sene D, Resche-Rigon M, Cacoub P. Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum. 2011;63(6):1748-1757.